Display options
Cite
Quon H, Loblaw DA. Androgen deprivation therapy for prostate cancer-review of indications in 2010. Curr Oncol. 2010;17:S38-44doi: 10.3747/co.v17i0.698.
Quon, H., & Loblaw, D. A. (2010). Androgen deprivation therapy for prostate cancer-review of indications in 2010. Current oncology (Toronto, Ont.), 17S38-44. https://doi.org/10.3747/co.v17i0.698
Quon, H, and Loblaw, D A. "Androgen deprivation therapy for prostate cancer-review of indications in 2010." Current oncology (Toronto, Ont.) vol. 17 (2010): S38-44. doi: https://doi.org/10.3747/co.v17i0.698
Quon H, Loblaw DA. Androgen deprivation therapy for prostate cancer-review of indications in 2010. Curr Oncol. 2010 Sep;17:S38-44. doi: 10.3747/co.v17i0.698. PMID: 20882131; PMCID: PMC2935708.
Copy Download .nbib Format: NLM
Share it on

Curr Oncol. 2010 Sep;17:S38-44. doi: 10.3747/co.v17i0.698.

Androgen deprivation therapy for prostate cancer-review of indications in 2010.

Current oncology (Toronto, Ont.)

H Quon, D A Loblaw

Affiliations

  1. Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON.

PMID: 20882131 PMCID: PMC2935708 DOI: 10.3747/co.v17i0.698

Abstract

The discovery of androgen deprivation therapy (ADT) has been one of the most important advances in the treatment of prostate cancer. Here, the indications for the use of ADT are reviewed, together with the data supporting each indication. The settings for ADT use include cytoreduction; combined ADT and radiotherapy; pathologic node-positive disease; and recurrent, metastatic, or progressive prostate cancer.

Keywords: Androgen antagonists; combined-modality therapy; disease progression; hormonal anti-neoplastic agents; orchiectomy; prostatectomy; prostatic neoplasms; radiotherapy

References

  1. Oncologist. 1997;2(1):18-27 - PubMed
  2. J Clin Oncol. 2010 Jan 1;28(1):126-31 - PubMed
  3. J Clin Oncol. 2008 May 20;26(15):2497-504 - PubMed
  4. Can Urol Assoc J. 2009 Dec;3(6):460-4 - PubMed
  5. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):980-8 - PubMed
  6. JAMA. 1998 Sep 16;280(11):969-74 - PubMed
  7. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1243-52 - PubMed
  8. Urology. 1992 Mar;39(3):254-61 - PubMed
  9. Prostate Cancer Prostatic Dis. 2004;7(3):217-22 - PubMed
  10. J Clin Oncol. 2010 Mar 1;28(7):1106-11 - PubMed
  11. Urology. 1997 Sep;50(3):330-6 - PubMed
  12. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74 - PubMed
  13. Lancet. 2002 Jul 13;360(9327):103-6 - PubMed
  14. Lancet. 2000 Apr 29;355(9214):1491-8 - PubMed
  15. Jpn J Clin Oncol. 2004 Jan;34(1):20-8 - PubMed
  16. J Urol. 2009 Mar;181(3):956-62 - PubMed
  17. Cancer. 1973 Nov;32(5):1126-30 - PubMed
  18. BJU Int. 2006 Feb;97(2):247-54 - PubMed
  19. Radiother Oncol. 2000 Nov;57(2):195-200 - PubMed
  20. Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):789-99 - PubMed
  21. J Clin Oncol. 2007 May 20;25(15):2035-41 - PubMed
  22. Lancet Oncol. 2006 Jun;7(6):472-9 - PubMed
  23. Ann Intern Med. 2000 Apr 4;132(7):566-77 - PubMed
  24. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):983-9 - PubMed
  25. Urology. 2001 Apr;57(4):727-32 - PubMed
  26. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):646-55 - PubMed
  27. JAMA. 2004 Aug 18;292(7):821-7 - PubMed
  28. Lancet. 2009 Jan 24;373(9660):301-8 - PubMed
  29. J Clin Oncol. 2007 Apr 20;25(12):1596-605 - PubMed
  30. J Urol. 2001 Aug;166(2):500-6; discussion 506-7 - PubMed
  31. Eur Urol. 1996;29(1):47-54 - PubMed
  32. N Engl J Med. 2009 Jun 11;360(24):2516-27 - PubMed
  33. J Clin Oncol. 2006 Apr 20;24(12):1868-76 - PubMed
  34. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):15-23 - PubMed
  35. BJU Int. 2008 Dec;102(11):1531-8 - PubMed
  36. N Engl J Med. 1996 Aug 22;335(8):533-9 - PubMed
  37. J Clin Oncol. 2004 Oct 15;22(20):4109-18 - PubMed
  38. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):407-12 - PubMed
  39. Cancer Invest. 1995;13(1):8-15 - PubMed
  40. J Urol. 2004 Sep;172(3):923-7 - PubMed
  41. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1285-90 - PubMed
  42. Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):33-7 - PubMed
  43. Lancet Oncol. 2005 Nov;6(11):841-50 - PubMed
  44. Lancet. 2005 Aug 13-19;366(9485):572-8 - PubMed
  45. Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1107-10 - PubMed
  46. Cancer. 2009 Aug 1;115(15):3437-45 - PubMed
  47. Urology. 2006 Jul;68(1):116-20 - PubMed
  48. Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):755-61 - PubMed
  49. Cancer. 2002 Jul 15;95(2):361-76 - PubMed

Publication Types